Financials Vimian Group AB

Equities

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:29:54 2024-04-29 am EDT 5-day change 1st Jan Change
30.05 SEK +2.21% Intraday chart for Vimian Group AB -3.69% +1.52%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 3,018 1,017 1,215 1,341 - -
Enterprise Value (EV) 1 3,143 1,017 1,492 1,595 1,471 1,341
P/E ratio 388 x -122 x 133 x 33.3 x 20.4 x 19.9 x
Yield - - - - - -
Capitalization / Revenue 17.4 x 3.61 x 3.66 x 3.61 x 3.2 x 2.83 x
EV / Revenue 18.1 x 3.61 x 4.5 x 4.29 x 3.51 x 2.83 x
EV / EBITDA 54.1 x 12.4 x 15.4 x 14.4 x 11 x 8.53 x
EV / FCF -31.8 x - -34.3 x 29.5 x 22.2 x 15.4 x
FCF Yield -3.15% - -2.92% 3.39% 4.51% 6.51%
Price to Book 7.59 x - 2.29 x 1.96 x 1.8 x 1.62 x
Nbr of stocks (in thousands) 389,191 416,173 457,118 522,421 - -
Reference price 2 7.755 2.443 2.658 2.566 2.566 2.566
Announcement Date 3/10/22 3/8/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 173.4 281.3 331.7 371.5 419.4 473.2
EBITDA 1 - 58.11 81.91 97.15 110.9 133.8 157.2
EBIT 1 - 41.42 54.68 65.11 77.36 98.64 120
Operating Margin - 23.9% 19.44% 19.63% 20.82% 23.52% 25.37%
Earnings before Tax (EBT) 1 - 12.76 0.924 19.45 49.97 85.47 114.2
Net income 1 52.79 6.586 -6.742 9.84 37.42 63.82 84.69
Net margin - 3.8% -2.4% 2.97% 10.07% 15.22% 17.9%
EPS 2 0.1800 0.0200 -0.0200 0.0200 0.0770 0.1255 0.1293
Free Cash Flow 1 - -98.98 - -43.48 54 66.33 87.33
FCF margin - -57.1% - -13.11% 14.54% 15.82% 18.46%
FCF Conversion (EBITDA) - - - - 48.68% 49.56% 55.55%
FCF Conversion (Net income) - - - - 144.3% 103.94% 103.12%
Dividend per Share 2 - - - - - - -
Announcement Date 6/9/21 3/10/22 3/8/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 41.49 48.7 67.94 67.03 70.88 75.46 88.1 81.31 79.88 82.46 94.42 92.18 90.32 95.67 108.7
EBITDA 1 12.93 13.18 22.13 19.91 19.22 20.64 28.23 22.75 20.73 25.44 30.25 27.3 26.7 28.9 32.79
EBIT 1 4.467 8.713 15.9 13.62 8.826 12.72 21.16 14.47 12.51 16.96 21.54 18.72 18.91 21.85 24.48
Operating Margin 10.77% 17.89% 23.41% 20.32% 12.45% 16.86% 24.02% 17.8% 15.67% 20.57% 22.81% 20.31% 20.93% 22.84% 22.52%
Earnings before Tax (EBT) 1 2.441 1.892 8.911 11.1 -0.627 -18.46 9.085 6.92 9.8 -6.357 12.9 10.7 12.85 13.85 20
Net income 1 -0.275 2.024 5.424 9.992 -1.618 -20.54 5.405 2.994 7.432 -6.458 9.8 8.6 8.3 10.5 15
Net margin -0.66% 4.16% 7.98% 14.91% -2.28% -27.22% 6.14% 3.68% 9.3% -7.83% 10.38% 9.33% 9.19% 10.98% 13.8%
EPS 2 - 0.0100 0.0100 0.0300 - -0.0500 0.0100 0.0100 0.0200 -0.0100 0.0242 0.0191 0.0184 0.0288 0.0257
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/26/21 3/10/22 5/24/22 8/24/22 11/16/22 3/8/23 5/4/23 8/17/23 11/8/23 2/15/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 125 - 276 254 130 -
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 2.155 x - 2.844 x 2.29 x 0.9741 x -
Free Cash Flow 1 - -99 - -43.5 54 66.3 87.3
ROE (net income / shareholders' equity) - 6.41% - 4.5% 5.81% 6.97% 6.96%
ROA (Net income/ Total Assets) - 3.43% - 2.39% 2.99% 4.85% 5.84%
Assets 1 - 192.2 - 411.3 1,252 1,316 1,451
Book Value Per Share 2 - 1.020 - 1.160 1.310 1.420 1.580
Cash Flow per Share - - - - - - -
Capex 1 - 5.41 - 14.9 13.2 14.5 17.1
Capex / Sales - 3.12% - 4.49% 3.54% 3.46% 3.6%
Announcement Date 6/9/21 3/10/22 3/8/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.566 EUR
Average target price
3.355 EUR
Spread / Average Target
+30.72%
Consensus
  1. Stock Market
  2. Equities
  3. VIMIAN Stock
  4. Financials Vimian Group AB